AP NEWS

2018 Advancements in Biomarker Assays and Stem Cell Therapies - ResearchAndMarkets.com

September 28, 2018

DUBLIN--(BUSINESS WIRE)--Sep 28, 2018--The “Advancements in Biomarker Assays and Stem Cell Therapies” report has been added to ResearchAndMarkets.com’s offering.

This report presents trends across biomarker assays and stem cell therapies: a blood test for traumatic brain injury, use of umbilical cord mesenchymal stem cells and adipose-derived mesenchymal stem cells for treatment of liver cirrhosis, and using mesenchymal stem cells for treatment of ulcerative colitis are profiled. The corresponding clinical trials scenario is also depicted.

Key Topics Covered

Novel Blood Test for Traumatic Brain Injury Umbilical Cord Mesenchymal Stem Cells for Liver Cirrhosis Adipose-derived Mesenchymal Stem Cells for Liver Cirrhosis Mesenchymal Stem Cell Therapy to Treat Ulcerative Colitis Clinical Trial Analysis of Studies Conducted by Banyan Biomarkers Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/zmnv52/2018_advancements?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180928005667/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Stem Cells ,Biomarkers

KEYWORD:

INDUSTRY KEYWORD: STEM CELLS HEALTH BIOTECHNOLOGY CLINICAL TRIALS GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/28/2018 06:17 PM/DISC: 09/28/2018 06:17 PM

http://www.businesswire.com/news/home/20180928005667/en

AP RADIO
Update hourly